-
Price Momentum
YARW is trading near the bottom of its 52-week range and below its 200-day simple moving average.
-
Price change
The price of YARW shares has increased $2.00 since the market last closed. This is a 14.71% rise.
-
Closed at $15.60.
The stock has remained unchanged in after-hours trading.
Key terms
About YARW
Yarrow Bioscience, Inc. is a clinical-stage biotechnology company focused on developing transformative therapies for autoimmune thyroid diseases. The company is developing YB-101, a potentially first-of-its-kind antibody therapy aimed at treating Graves disease (GD) and thyroid eye disease (TED). Yarrow Bioscience was founded in October 2025 and is headquartered in New Haven, CT.
-
Market cap: $147.23M
A market capitalization up to $300 million places YARW in the micro-capitalization category.
Key terms
Smart score
Latest YARW news
No recent press releases are available for YARW
YARW Financials
-
Total revenue: $570.00K (1Y), $97.00K (Q2)
Total Revenue increased 13.77% since last year and increased 12.79% since last quarter.
-
Net income: -$26.48M (1Y), -$2.90M (Q2)
Net Income increased 33.52% since last year and increased 19.14% since last quarter.
-
Earnings per share: -$30.96 (1Y), -$3.50 (Q2)
EPS increased 33.8% since last year and increased 16.38% since last quarter.
Key terms
YARW Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
YARW Competitors
-
How competitors are chosen
YARW's competitors are included in the Health Technology sector and Pharmaceuticals: Major group
-
Market cap: $147.23M
A market capitalization up to $300 million places YARW in the micro-capitalization category.
